Filing Flows

Filing Flows › Companies › Precision Biosciences › Cash flow

Precision Biosciences cash flow, quarter by quarter

Latest: Q1 FY27 · from the cash-flow statements filed with the SEC

Free cash flow−$15.1M in Q1 FY27

Operating cash flow−$15.1M
Free cash flow−$15.1M

Analysis

In Q1 FY27, Precision Biosciences generated −$15.1M of operating cash flow. That is $138K more than in Q1 FY26 (−$15.3M).

Operating cash flow was −$15.1M against net income of −$7.6M. The largest differences: stock-based pay +$3.0M, prepaid and other assets −$729K, depreciation & amortization +$222K.

Free cash flow

Precision Biosciences: free cash flow by quarterPrecision Biosciences: free cash flow by quarter−$18.8MQ2 FY25−$19.1MQ3 FY25−$20.3MQ1 FY26−$15.3MQ1 FY26−$11.3MQ2 FY26−$12.0MQ3 FY26−$13.4MQ1 FY27−$15.1MQ1 FY27
Operating cash flow less capital spending.
Precision Biosciences: operating cash flow against capital spendingPrecision Biosciences: operating cash flow against capital spendingOperating cash flowCapital spending−$18.7M$97KQ2 FY25−$19.1M$64KQ3 FY25−$20.3M$2KQ1 FY26−$15.3M$0Q1 FY26−$11.2M$19KQ2 FY26−$11.9M$18KQ3 FY26−$13.4M$0Q1 FY27−$15.1M$0Q1 FY27
Latest (Q1 FY27): Operating cash flow −$15.1M, Capital spending $0.

Cash runway and the debt wall

Cash & investments$81.8M
Debtnone
Net cash$81.8M
Cash runway16 months

Precision Biosciences is burning cash: its operations consume cash, a free cash flow of −$60.5M a year at the current rate against $81.8M of cash and investments: a runway of about 16 months before any new financing.

Where the cash came from and went

Precision Biosciences: sources (+) and uses (−) of cash, Q1 FY27Precision Biosciences: sources (+) and uses (−) of cash, Q1 FY27Operating cash flow−$15.1MOther financing$11.0MCash drawn (+) / kept (−)$4.4MOther investing−$200K

From profit to cash

Precision Biosciences: net income to operating cash flow, Q1 FY27Precision Biosciences: net income to operating cash flow, Q1 FY27Net income−$7.6MDepreciation & amortization$222KStock-based pay$3.0MPayables−$29KPrepaid and other assets−$729KOperating cash flow−$15.1M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.

Every quarter

QuarterOperating cash flowCapital spendingNet borrowing (+) / repaid (−)Cash drawn (+) / kept (−)Free cash flow
Q1 FY27−$15.1M——$4.4M−$15.1M
Q1 FY27−$13.4M——$13.4M−$13.4M
Q3 FY26−$11.9M−$18K—$11.3M−$12.0M
Q2 FY26−$11.2M−$19K—−$65.9M−$11.3M
Q1 FY26−$15.3M——$13.6M−$15.3M
Q1 FY26−$20.3M−$2K—$15.0M−$20.3M
Q3 FY25−$19.1M−$64K—$8.7M−$19.1M
Q2 FY25−$18.7M−$97K−$20K$12.9M−$18.8M

Precision Biosciences: income statement and cash flow

Precision Biosciences, Q3 FY26: revenue $10.8M (374× year over year), operating margin -83.7%. The chart follows the revenue to costs, profit and cash.

Precision Biosciences: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.